# FDA Inspection 1000200 - Good Samaritan Hospital - January 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/good-samaritan-hospital/6d514385-8cb4-46bd-b602-2c446b3d29fb
Source feed: FDA_Inspections

> FDA Inspection 1000200 for Good Samaritan Hospital on January 20, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1000200
- Company Name: Good Samaritan Hospital
- Inspection Date: 2017-01-20
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 921980 - 2015-04-13](https://www.keypedia.com/records/fda_inspections/good-samaritan-hospital/8d7eff52-910c-40ed-8af1-906df7b28b9f)
- [FDA Inspection 830670 - 2013-05-01](https://www.keypedia.com/records/fda_inspections/good-samaritan-hospital/ab906de9-a8d8-470e-ab66-5aa65a20a900)
- [FDA Inspection 706969 - 2011-02-01](https://www.keypedia.com/records/fda_inspections/good-samaritan-hospital/84cbdea0-4d10-4052-b492-35bd03cc3251)
- [FDA Inspection 604485 - 2009-09-03](https://www.keypedia.com/records/fda_inspections/good-samaritan-hospital/5f7122ff-cd13-4e3a-862e-3a4aee18a148)

Company: https://www.keypedia.com/companies/good-samaritan-hospital/910b99ce-c027-4264-8dac-dc2c5c92f09f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d